Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
136,962,515
-
Share change
-
+7,525,422
-
Total reported value
-
$874,976,759
-
Put/Call ratio
-
75%
-
Price per share
-
$6.39
-
Number of holders
-
158
-
Value change
-
+$48,445,188
-
Number of buys
-
63
-
Number of sells
-
90
Institutional Holders of ARIAD PHARMACEUTICALS INC - COM (ARIA) as of Q1 2016
As of 31 Mar 2016,
ARIAD PHARMACEUTICALS INC - COM (ARIA) was held by
158 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
136,962,515 shares.
The largest 10 holders included
PUTNAM INVESTMENTS LLC, Sarissa Capital Management LP, VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, BlackRock Fund Advisors, STATE STREET CORP, Consonance Capital Management LP, Camber Capital Management LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and PointState Capital LP.
This page lists
158
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.